Open Non-Comparative Study To Evaluate Administration Of a New Nutraceutical

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 27, 2018

Primary Completion Date

May 24, 2019

Study Completion Date

May 24, 2019

Conditions
Sleep Disorder
Interventions
DIETARY_SUPPLEMENT

Sonidor®

Sonidor® triple layer release tablets are developed with a specialized process to improve stability and bioavailability of the formulation based on hawthorn, lavender and hop extracts. The hawthorn, lavender and hop extracts used to product Sonidor® have an elevated content of vitexin (3%), monoterpens (4% as linalool) and flavonoids (4%), respectively.

Trial Locations (1)

Unknown

Fizio Center, Timișoara

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

Italfarmaco

INDUSTRY